Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee

Journal of Rheumatology

Volumn 32, Issue 12, 2005, Pages 2384-2392

  Niethard, Fritz U ^a   Gold, Morris S ^b   Solomon, Gail S ^c   Liu, Jiun Min ^c   Unkauf, Markus ^e,f   Albrecht, Helmut H ^c   Elkik, Francois ^d  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Biostatistics and Data Management ^*

^c Pre Clinical and Clinical Development and Drug Safety

^d Clinical Research   (United States)

^e Novartis Consumer Health   (Germany)

^f Novartis Consumer Health   (Germany)

Author keywords

Diclofenac; Knee; Nonsteroidal antiinflammatory drug; Osteoarthritis; Topical; Western Ontario nd McMaster osteoarthritis index

Indexed keywords

DICLOFENAC; DICLOFENAC DIETHYLAMINE; PARACETAMOL; PLACEBO;

ADULT; ANALGESIA; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FEMALE; GEL; HUMAN; INFLAMMATION; KNEE FUNCTION; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; SKIN IRRITATION; XEROSTOMIA;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; GELS; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MOVEMENT; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 28844455481     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59:936-44.
2. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15.
3. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998;316:333-8.
4. Case JP, Baliunas AJ, Block JA. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis. Arch Intern Med 2003;163:169-78.
5. Heyneman CA, Lawless-Liddy C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases. Drugs 2000;60:555-74.
6. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
7. Pham T, van der Heijde D, Lassere M, et al. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. J Rheumatol 2003;30:1648-54.
8. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004;329:324. Epub 2004 July 30.
9. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 2004;5:10.
10. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskeletal Disorders 2004;5:28. doi: 10.1186/1471-2474-5-28.
11. Bookman AAM, Williams KSA, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled study. Can Med Assoc J 2004;171:333-8.
12. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee. Arch Intern Med 2004;164:2017-23.
13. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in the symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 2004;31:2002-12.
14. Zacher H, Burger KJ, Färber L, et al. Topisches diclofenac emulgel versus orales ibuprofen in der therapie der aktivierten arthrose der fingergelenke (Heberden- und/oder Bouchard-arthrose). Doppelblinde, kontrollierte, randomisierte studie. Akt Rheumatol 2001;26:7-14.
15. Reiter S. Topische nichtstereoidale antirheumatika. Aspekte zur planung und auswertung klinischer studien und ergebnissbewertung im zulassungsverfahren. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2000;43:950-9.
16. Bellamy N, Carr A, Dougados M, Shea B, Wells G. Towards a definition of difference in osteoarthritis. J Rheumatol 2001;28:427-30.
17. Eberle E, Ottillinger B. Clinically relevant change and clinically relevant difference in knee osteoarthritis. Osteoarthritis Cartilage 1999;7:502-3.
18. Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities Osteoarthritis Index questionnaire and global assessment in patients with osteoarthritis. J Rheumatol 2000;27:2635-41.
19. Todd KH, Funk KG, Funk JP, Bonacci R. The clinical significance of reported changes in pain severity [abstract]. Acad Emerg Med 1995;2:369-70.
20. Kelly AM. Does the clinically significant difference in visual analog pain scores vary with gender, age, or cause of pain? Acad Emerg Med 1998;5:1086-90.
21. Wells GA, Tugwell P, Kraag GR, et al. Minimum important difference between patients with rheumatoid arthritis: The patient's perspective. J Rheumatol 1993;20:557-60.
22. Gondolph-Zink B, Gronwald U. Active substance concentration in articular and periarticular tissues of the knee joint after cutaneous application of diclofenac-diethylammonium emulgel. Akt Rheumatol 1996;21:298-304.
23. Rademacher J, Jentsch D, Scholl MA, Lustinetz T, et al. Diclofenac concentration in synovial fluid in inflammation and degenerative joint disease. Br J Pharmacol 1991;31:537-41.
24. Rolf C, Engström B, Beauchard C, Jacobs D, Le Libour A. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology Oxford 1999;38:564-7.
25. Cordero JA, Camacho M, Obach R, Domenech J, Vila L. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharmaceutics Biopharmaceuticals 2001;51:135-42.